Diovan HCT (valsartan)

Company
Novartis

Approval Status
Approved March 1998

Treatment for
second-line treatment of hypertension

Possible similar drugs
Diovan; Diovan

Areas
Cardiovascular / Cardiology , Diabetes / Endocrinology

Diovan HCT has been approved for second-line treatment of hypertension. Diovan HCT is a combination of an angiotensin II receptor blocker (ARB)--a first line treatment that lowers blood pressure with an overall incidence of side effects comparable to placebo--and a diuretic, which is commonly used with other therapies to provide additional blood pressure lowering.

Diovan HCT (valsartan) Drug Information

The Diovan HCT (valsartan) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top